Medical cannabis in the UK: from principle to practice
Background: In the UK, medical cannabis was approved in November 2018, leading many
patients to believe that the medicine would now be available on the NHS. Yet, to date, there …
patients to believe that the medicine would now be available on the NHS. Yet, to date, there …
Cannabis-based medicines and the perioperative physician
P Tapley, S Kellett - Perioperative Medicine, 2019 - Springer
The increasing availability of cannabis for both recreational and medicinal purposes means
that anaesthetists will encounter an increasing number of patients taking cannabis-based …
that anaesthetists will encounter an increasing number of patients taking cannabis-based …
A perspective on cannabinoids for treating epilepsy: do they really change the landscape?
JH Cross, H Cock - Neuropharmacology, 2020 - Elsevier
With the licensing of cannabidiol for drug resistant seizures in Dravet and Lennox Gastaut
syndromes in the United states in 2018, interest in the potential for cannabis-based …
syndromes in the United states in 2018, interest in the potential for cannabis-based …
The ethics and management of cannabis use in pregnancy following decriminalisation and licensing for medical use: narrative review
A Towobola, B Towobola, B Nair, A Makwana - BJPsych Bulletin, 2023 - cambridge.org
Aims and methodAs drug policies pertaining to cannabis use become more liberalised, the
prevalence of cannabis use in pregnancy could increase. However, there is limited …
prevalence of cannabis use in pregnancy could increase. However, there is limited …
[HTML][HTML] “It's a big added stress on top of being so ill”: The challenges facing people prescribed cannabis in the UK
HB Wilson, LM McGrath - International Journal of Drug Policy, 2023 - Elsevier
Background This paper reports on the first qualitative study to interview people prescribed
cannabis in the UK. Cannabis is a class B controlled substance under the 1971 Misuse of …
cannabis in the UK. Cannabis is a class B controlled substance under the 1971 Misuse of …
Elicitation of stakeholder viewpoints about medical cannabis research for pain management in critically ill ventilated patients: A Q-methodology study
Objectives To determine acceptability of medical cannabis research in critically ill patients.
Design Q-methodology survey. Setting Convenience sample of healthcare providers and the …
Design Q-methodology survey. Setting Convenience sample of healthcare providers and the …
The effects of dexamphetamine, nabilone (a synthetic cannabinoid agonist), and caffeine on working memory, schizotypy and a tactile illusion in healthy volunteers
FM Kassim - 2021 - research-repository.uwa.edu.au
The thesis aimed to examine the effects of dopamine-releasing agents and cannabinoids on
working memory (WM), schizotypy and stimulus binding windows (BWs) by manipulating …
working memory (WM), schizotypy and stimulus binding windows (BWs) by manipulating …
[引用][C] Recommending marijuana use: Violation of the Hippocratic aphorism of “do good or do no harm”
AS Manolis, TA Manolis - European Journal of Internal Medicine, 2019 - ejinme.com
Legalization of medical or recreational use of marijuana presupposes that all drug-
formulations have been tested and proven safe. However, this has not been the case with …
formulations have been tested and proven safe. However, this has not been the case with …